Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.14 billion.
Market Cap
1.12T
Revenue
110.14B
Profits
-39.68B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.62B | 0.16% | 1,188,409 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.76B | 0.60% | 627,150 | 14.34B |
| 3 | ARGX | argenx SE | 46.54B | 1.76% | 365,175 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.60B | -0.65% | 672,944 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.54B | 0.82% | 2,850,929 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 34.20B | 3.86% | 343,204 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 27.97B | 1.08% | 3,834,451 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.46B | 0.61% | 617,266 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.93B | 0.51% | 7,120,478 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 19.84B | -1.52% | 7,602,579 | 1.94B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.55B | 1.43% | 2,183,808 | - |
| 12 | INCY | Incyte Corporation | 18.77B | 0.19% | 1,479,390 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | 1.45% | 681,231 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.67B | -0.21% | 2,374,602 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.43B | 0.26% | 2,254,108 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.01B | -0.21% | 484,541 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.41B | 0.05% | 1,663,675 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.15B | 1.22% | 422,783 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.59B | -0.41% | 687,010 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.44B | 2.68% | 1,872,053 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.01B | 1.33% | 2,229,692 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.38B | 3.25% | 1,091,386 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.89B | -0.90% | 439,003 | 7.46M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.81B | 0.35% | 1,676,172 | 1.09B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.79B | 1.63% | 604,031 | 638.50M |
| 26 | PCVX | Vaxcyte, Inc. | 8.42B | 0.69% | 2,689,991 | - |
| 27 | TECH | Bio-Techne Corporation | 8.37B | 2.33% | 2,458,558 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.31B | 3.11% | 1,006,617 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.20B | 1.06% | 2,365,114 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.75B | 1.19% | 1,760,998 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.57B | 0.23% | 350,882 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.37B | -6.91% | 19,382,477 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.93B | 1.97% | 667,357 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | -0.06% | 960,866 | 22.29M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | -1.64% | 583,084 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.58B | 4.90% | 161,162 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.22B | 0.08% | 692,924 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.35% | 11,441,825 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.13% | 8,359,326 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 1.32% | 945,363 | 189.76M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | 2.42% | 873,315 | 521.31M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.69B | 0.91% | 1,043,690 | 1.73B |
| 43 | COGT | Cogent Biosciences, Inc. | 5.68B | -8.44% | 8,616,848 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.67B | 0.39% | 2,633,262 | - |
| 45 | CGON | CG Oncology, Inc. | 5.64B | -1.32% | 1,160,284 | 4.04M |
| 46 | CELC | Celcuity Inc. | 5.46B | -1.06% | 736,578 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -2.51% | 1,379,772 | 7.50M |
| 48 | CAI | Caris Life Sciences, Inc. | 5.41B | 6.99% | 2,408,729 | 812.03M |
| 49 | APLS | Apellis Pharmaceuticals, Inc. | 5.16B | 0.40% | 30,394,890 | 1.00B |
| 50 | ERAS | Erasca, Inc. | 5.16B | 2.60% | 5,241,368 | - |
| 51 | IMVT | Immunovant, Inc. | 5.11B | 1.05% | 699,413 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.96B | 1.08% | 1,829,117 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.69B | 2.61% | 1,310,054 | 3.51M |
| 54 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.14% | 4,090,435 | 634.21M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.48B | 0.76% | 1,103,211 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.47B | 4.14% | 1,944,994 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | -0.02% | 261,868 | 268.09M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.84B | -3.05% | 890,620 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.83B | 0.69% | 1,099,690 | 7.70M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.81B | 1.29% | 2,240,678 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 0.27% | 1,612,706 | 1.07B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.77B | 2.50% | 994,135 | 22.50M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | 5.21% | 1,593,569 | - |
| 64 | GPCR | Structure Therapeutics Inc. | 3.55B | 4.09% | 1,356,813 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.52B | 5.31% | 1,073,741 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.12B | 2.50% | 1,912,319 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.10B | -3.45% | 176,333 | 803.79M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | 0.24% | 1,446,380 | 588.99M |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.03B | 1.43% | 2,561,080 | 62.38M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | 2.29% | 1,348,861 | 376.07M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 0.10% | 350,671 | 451.36M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.99B | -0.17% | 1,430,711 | - |
| 73 | TVTX | Travere Therapeutics, Inc. | 2.90B | 5.76% | 2,277,456 | 490.73M |
| 74 | ALMS | Alumis Inc. | 2.89B | 3.18% | 1,610,776 | 24.05M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.89B | 0.67% | 1,617,984 | - |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | -2.52% | 813,476 | 218.71M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.74B | 1.11% | 1,478,498 | 247.00M |
| 78 | KOD | Kodiak Sciences Inc. | 2.64B | 12.30% | 2,621,070 | - |
| 79 | IMNM | Immunome, Inc. | 2.54B | 2.65% | 1,148,116 | 6.94M |
| 80 | ORKA | Oruka Therapeutics, Inc. | 2.50B | 2.81% | 1,013,469 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.47B | 1.31% | 948,428 | - |
| 82 | AAPG | Ascentage Pharma Group International | 2.44B | 10.10% | 8,181 | 82.08M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.41B | 1.64% | 2,092,320 | 139.74M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.32B | 1.70% | 2,074,580 | 2.20B |
| 85 | ZLAB | Zai Lab Limited | 2.29B | 8.13% | 1,245,794 | 460.16M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.26B | -3.60% | 840,993 | - |
| 87 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | 3.96% | 2,485,642 | 276.98M |
| 88 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.09% | 971,207 | 158.18M |
| 89 | MANE | Veradermics, Incorporated | 2.19B | -6.92% | 625,551 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.18B | -2.51% | 1,068,928 | - |
| 91 | NKTR | Nektar Therapeutics | 2.17B | 5.23% | 1,301,630 | 55.23M |
| 92 | ADMA | ADMA Biologics, Inc. | 2.17B | 1.11% | 7,793,862 | 510.17M |
| 93 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | 2.23% | 2,275,889 | 172.35M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.10B | 2.24% | 2,310,380 | 673.00M |
| 95 | CLDX | Celldex Therapeutics, Inc. | 2.08B | -1.45% | 432,960 | 1.55M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.06B | -0.05% | 826,083 | - |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 4.39% | 1,492,530 | 283.06M |
| 98 | DFTX | Definium Therapeutics, Inc. | 2.05B | 8.99% | 3,219,177 | - |
| 99 | MESO | Mesoblast Limited | 2.03B | 2.73% | 464,854 | 65.38M |
| 100 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 1.06% | 1,556,073 | 54.03M |
| 101 | GLPG | Galapagos NV | 1.98B | -0.80% | 348,320 | 1.31B |
| 102 | VRDN | Viridian Therapeutics, Inc. | 1.96B | -2.10% | 2,859,792 | 70.85M |
| 103 | RLAY | Relay Therapeutics, Inc. | 1.92B | 8.24% | 2,400,519 | 15.36M |
| 104 | ZYME | Zymeworks Inc. | 1.91B | 3.59% | 1,136,109 | 105.97M |
| 105 | PHVS | Pharvaris N.V. | 1.91B | 4.25% | 502,006 | - |
| 106 | SLNO | Soleno Therapeutics, Inc. | 1.91B | 10.48% | 2,924,580 | 190.41M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.89B | -1.75% | 686,238 | 184.42M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.86B | 3.02% | 516,346 | - |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -1.65% | 3,349,048 | 51.95M |
| 110 | INVA | Innoviva, Inc. | 1.73B | 0.47% | 617,939 | 411.33M |
| 111 | CAPR | Capricor Therapeutics, Inc. | 1.73B | -0.92% | 1,860,028 | 11.13M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -3.43% | 358,319 | - |
| 113 | GENB | Generate Biomedicines, Inc. | 1.70B | 6.48% | 389,383 | 31.89M |
| 114 | VCEL | Vericel Corporation | 1.66B | 1.21% | 647,317 | 276.26M |
| 115 | ANAB | AnaptysBio, Inc. | 1.63B | 2.29% | 1,209,061 | 234.60M |
| 116 | NBTX | Nanobiotix S.A. | 1.63B | 10.37% | 128,619 | 11.93M |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | -0.18% | 692,240 | 868.45M |
| 118 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -0.33% | 10,858,247 | 74.68M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -0.13% | 908,749 | 83.98M |
| 120 | OCS | Oculis Holding AG | 1.60B | 1.65% | 353,974 | 1.51M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 3.51% | 3,025,559 | 67.67M |
| 122 | NUVB | Nuvation Bio Inc. | 1.55B | 5.13% | 3,056,670 | 62.90M |
| 123 | IMCR | Immunocore Holdings plc | 1.54B | 0.53% | 437,029 | 400.02M |
| 124 | MBX | MBX Biosciences, Inc. | 1.53B | 8.17% | 405,401 | - |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.21% | 287,809 | - |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.51B | -3.17% | 166,262 | - |
| 127 | ARDX | Ardelyx, Inc. | 1.50B | 2.00% | 6,441,456 | 407.32M |
| 128 | TRVI | Trevi Therapeutics, Inc. | 1.49B | -2.93% | 1,419,781 | - |
| 129 | BHVN | Biohaven Ltd. | 1.45B | 13.71% | 3,496,309 | - |
| 130 | MAZE | Maze Therapeutics, Inc. | 1.44B | -2.68% | 933,965 | 2.50M |
| 131 | VIR | Vir Biotechnology, Inc. | 1.44B | 0.67% | 2,085,595 | 68.56M |
| 132 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | -1.71% | 9,267,863 | 263.50M |
| 133 | SVRA | Savara Inc. | 1.41B | 2.20% | 1,203,768 | - |
| 134 | PGEN | Precigen, Inc. | 1.39B | 1.55% | 5,747,868 | 9.68M |
| 135 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 4.38% | 2,414,236 | 123.67M |
| 136 | ATAI | AtaiBeckley Inc. | 1.35B | 4.52% | 2,493,973 | 4.09M |
| 137 | IMTX | Immatics N.V. | 1.34B | 1.73% | 303,161 | 56.67M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.34B | 3.07% | 678,983 | - |
| 139 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 1.41% | 1,138,756 | - |
| 140 | NVAX | Novavax, Inc. | 1.31B | -1.47% | 2,792,241 | 1.12B |
| 141 | WVE | Wave Life Sciences Ltd. | 1.29B | -5.79% | 5,381,369 | 42.73M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -3.58% | 1,652,367 | 9.77M |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -1.37% | 1,223,211 | - |
| 144 | DBVT | DBV Technologies S.A. | 1.21B | -1.87% | 404,662 | 5.64M |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 4.14% | 1,987,486 | 10.00M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.18B | -11.37% | 4,454,194 | - |
| 147 | PHAR | Pharming Group N.V. | 1.16B | 1.68% | 2,470 | 376.13M |
| 148 | SEPN | Septerna, Inc. | 1.09B | 1.41% | 210,238 | 45.95M |
| 149 | EYPT | EyePoint, Inc. | 1.09B | 1.01% | 885,070 | 31.37M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.07B | 4.98% | 1,041,002 | - |
| 151 | ABCL | AbCellera Biologics Inc. | 1.06B | 0.57% | 1,665,168 | 75.13M |
| 152 | GERN | Geron Corporation | 1.06B | 11.41% | 26,474,061 | 183.88M |
| 153 | QURE | uniQure N.V. | 1.06B | 3.30% | 1,405,640 | 16.10M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 4.14% | 2,314,657 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.01B | -2.16% | 641,553 | 9.31M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -1.79% | 1,288,005 | 73.62M |
| 157 | CTMX | CytomX Therapeutics, Inc. | 985.77M | -2.98% | 5,028,375 | 76.20M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 979.40M | -0.27% | 178,623 | 1.30M |
| 159 | CMPX | Compass Therapeutics, Inc. | 977.88M | 2.65% | 1,912,443 | 850.00K |
| 160 | AKTS | Aktis Oncology, Inc. | 943.56M | -4.58% | 381,902 | 6.50M |
| 161 | URGN | UroGen Pharma Ltd. | 922.04M | 5.34% | 599,906 | 109.79M |
| 162 | XNCR | Xencor, Inc. | 918.93M | 3.90% | 1,029,819 | 125.58M |
| 163 | MPLT | MapLight Therapeutics, Inc. | 917.02M | 2.46% | 283,735 | - |
| 164 | GHRS | GH Research PLC | 913.07M | 4.69% | 135,466 | - |
| 165 | FTRE | Fortrea Holdings Inc. | 889.19M | 0.96% | 999,659 | 2.72B |
| 166 | ABUS | Arbutus Biopharma Corporation | 883.56M | 0.44% | 1,197,862 | 14.08M |
| 167 | JANX | Janux Therapeutics, Inc. | 882.67M | 4.39% | 1,029,958 | 10.00M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 877.82M | 0.27% | 944,298 | 175.11M |
| 169 | OMER | Omeros Corporation | 869.71M | 14.39% | 4,637,788 | - |
| 170 | ANNX | Annexon, Inc. | 860.14M | -3.25% | 2,450,620 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 843.73M | -1.90% | 669,669 | - |
| 172 | TBPH | Theravance Biopharma, Inc. | 815.65M | -2.40% | 677,047 | 107.46M |
| 173 | SGP | SpyGlass Pharma, Inc. | 814.28M | -5.67% | 88,798 | - |
| 174 | SANA | Sana Biotechnology, Inc. | 813.94M | 5.90% | 3,003,817 | - |
| 175 | EVMN | Evommune, Inc. | 807.53M | -2.48% | 342,498 | 13.00M |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 805.30M | 1.00% | 1,294,543 | 84.28M |
| 177 | TENX | Tenax Therapeutics, Inc. | 804.81M | 0.06% | 557,354 | - |
| 178 | JBIO | Jade Biosciences, Inc. | 790.05M | 14.02% | 2,237,451 | - |
| 179 | MNKD | MannKind Corporation | 782.58M | 3.67% | 3,475,858 | 348.97M |
| 180 | SLS | SELLAS Life Sciences Group, Inc. | 756.04M | -0.47% | 4,744,659 | - |
| 181 | ORIC | ORIC Pharmaceuticals, Inc. | 750.18M | -41.00% | 15,619,488 | - |
| 182 | ANRO | Alto Neuroscience, Inc. | 747.84M | 4.14% | 448,951 | - |
| 183 | RLMD | Relmada Therapeutics, Inc. | 744.72M | 2.01% | 1,738,648 | - |
| 184 | MGTX | MeiraGTx Holdings plc | 740.35M | 4.97% | 1,165,238 | 81.39M |
| 185 | MRVI | Maravai LifeSciences Holdings, Inc. | 737.78M | 1.41% | 2,213,440 | 185.74M |
| 186 | KURA | Kura Oncology, Inc. | 736.67M | 2.58% | 1,359,881 | 67.48M |
| 187 | SLDB | Solid Biosciences Inc. | 726.13M | 2.50% | 903,439 | - |
| 188 | ARVN | Arvinas, Inc. | 724.68M | 6.89% | 1,974,974 | 262.60M |
| 189 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 722.70M | 0.89% | 325,181 | - |
| 190 | VOR | Vor Biopharma Inc. | 722.03M | -2.52% | 1,563,408 | - |
| 191 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.84M | 5.13% | 2,904,303 | 49.80M |
| 192 | DRUG | Bright Minds Biosciences Inc. | 691.10M | -1.71% | 318,112 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 679.01M | 3.48% | 331,738 | - |
| 194 | GYRE | Gyre Therapeutics, Inc. | 660.20M | 3.73% | 68,747 | 116.59M |
| 195 | CBIO | Crescent Biopharma, Inc. | 641.69M | 5.17% | 442,072 | 10.84M |
| 196 | REPL | Replimune Group, Inc. | 628.38M | -0.52% | 1,095,104 | - |
| 197 | LBRX | LB Pharmaceuticals Inc | 627.67M | 0.61% | 199,683 | - |
| 198 | ALLO | Allogene Therapeutics, Inc. | 624.07M | 4.92% | 5,043,512 | 22.00K |
| 199 | DRTS | Alpha Tau Medical Ltd. | 609.03M | -2.12% | 147,370 | - |
| 200 | OCGN | Ocugen, Inc. | 604.84M | -1.10% | 7,315,622 | 4.41M |
| 201 | PRME | Prime Medicine, Inc. | 600.30M | -2.59% | 2,195,971 | 4.63M |
| 202 | MDXG | MiMedx Group, Inc. | 586.84M | - | 1,456,848 | 418.63M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 577.94M | -0.42% | 158,862 | - |
| 204 | ACRS | Aclaris Therapeutics, Inc. | 575.44M | 10.40% | 1,403,527 | 7.83M |
| 205 | AGMB | AgomAb Therapeutics NV | 574.12M | 12.30% | 549,540 | - |
| 206 | ZURA | Zura Bio Limited | 572.13M | 1.34% | 533,693 | - |
| 207 | VALN | Valneva SE | 569.36M | 0.32% | 274,523 | 205.07M |
| 208 | CRMD | CorMedix Inc. | 554.93M | 3.39% | 1,168,665 | 311.71M |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 552.48M | 0.97% | 539,713 | 106.47M |
| 210 | EIKN | Eikon Therapeutics, Inc. | 544.16M | -4.73% | 230,384 | - |
| 211 | PRTA | Prothena Corporation plc | 539.94M | 3.19% | 592,674 | 9.68M |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 530.19M | 1.62% | 825,937 | - |
| 213 | PROK | ProKidney Corp. | 528.35M | -2.23% | 886,809 | 893.00K |
| 214 | YDES | YD Bio Limited | 512.63M | -5.32% | 20,351 | 510.36K |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 508.01M | 1.70% | 246,670 | 294.28M |
| 216 | UPB | Upstream Bio, Inc. | 506.65M | 3.44% | 848,430 | 2.85M |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 503.88M | 6.02% | 686,475 | 85.21M |
| 218 | VTVT | vTv Therapeutics Inc. | 502.96M | 3.33% | 30,294 | 17.00K |
| 219 | CTNM | Contineum Therapeutics, Inc. | 502.17M | 2.99% | 156,309 | - |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 498.17M | -2.48% | 737,641 | 80.00M |
| 221 | VSTM | Verastem, Inc. | 487.48M | 4.72% | 2,926,418 | 30.91M |
| 222 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 4.00% | 1,840,806 | - |
| 223 | TRDA | Entrada Therapeutics, Inc. | 485.28M | 6.81% | 257,054 | 25.42M |
| 224 | LYEL | Lyell Immunopharma, Inc. | 485.02M | 3.74% | 97,677 | 36.00K |
| 225 | ADCT | ADC Therapeutics SA | 482.77M | 1.33% | 744,257 | 81.36M |
| 226 | ABSI | Absci Corporation | 482.02M | 5.00% | 3,232,724 | 2.80M |
| 227 | ASMB | Assembly Biosciences, Inc. | 466.84M | 6.05% | 77,747 | 72.30M |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.57M | 1.24% | 67,992 | - |
| 229 | IMMX | Immix Biopharma, Inc. | 456.55M | -5.38% | 679,837 | - |
| 230 | ENGN | enGene Holdings Inc. | 452.85M | -0.73% | 143,391 | - |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | 450.15M | 5.02% | 625,663 | - |
| 232 | STTK | Shattuck Labs, Inc. | 447.28M | -2.80% | 475,913 | 1.00M |
| 233 | RGNX | REGENXBIO Inc. | 445.42M | 2.98% | 526,022 | 170.44M |
| 234 | FBRX | Forte Biosciences, Inc. | 443.29M | -4.02% | 342,195 | - |
| 235 | AURA | Aura Biosciences, Inc. | 429.81M | 0.15% | 294,019 | - |
| 236 | NAUT | Nautilus Biotechnology, Inc. | 424.62M | -13.53% | 467,908 | - |
| 237 | LXEO | Lexeo Therapeutics, Inc. | 420.07M | -1.22% | 1,144,853 | - |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 417.89M | 2.32% | 1,087,876 | 216.11M |
| 239 | STRO | Sutro Biopharma, Inc. | 412.03M | -0.16% | 111,247 | 102.48M |
| 240 | ALT | Altimmune, Inc. | 405.93M | 1.30% | 2,111,437 | 41.00K |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 0.63% | 800,022 | 14.56M |
| 242 | XFOR | X4 Pharmaceuticals, Inc. | 395.50M | 5.33% | 446,548 | 35.11M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 395.23M | 10.77% | 1,061,999 | 170.16M |
| 244 | XOMA | XOMA Royalty Corporation | 394.05M | 5.42% | 169,809 | 52.15M |
| 245 | IPSC | Century Therapeutics, Inc. | 393.59M | -3.10% | 2,140,032 | 109.16M |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 393.02M | 1.12% | 3,553,966 | - |
| 247 | ARMP | Armata Pharmaceuticals, Inc. | 386.84M | 3.13% | 25,916 | 4.90M |
| 248 | AVTX | Avalo Therapeutics, Inc. | 380.57M | 11.86% | 952,018 | 59.00K |
| 249 | NMRA | Neumora Therapeutics, Inc. | 380.47M | 7.18% | 1,622,553 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 376.38M | 2.69% | 202,061 | 66.98M |
| 251 | IVVD | Invivyd, Inc. | 375.85M | 2.31% | 2,520,372 | 53.43M |
| 252 | BNTC | Benitec Biopharma Inc. | 375.78M | 3.38% | 101,474 | - |
| 253 | MNPR | Monopar Therapeutics Inc. | 370.15M | 1.10% | 121,278 | - |
| 254 | AUTL | Autolus Therapeutics plc | 367.28M | - | 1,529,198 | 75.39M |
| 255 | CADL | Candel Therapeutics, Inc. | 364.77M | 1.63% | 942,812 | - |
| 256 | NAGE | Niagen Bioscience, Inc. | 362.72M | 2.49% | 724,455 | 129.42M |
| 257 | PLYX | Polaryx Therapeutics, Inc. | 359.81M | 0.53% | 236,699 | - |
| 258 | PRTC | PureTech Health plc | 356.13M | 0.94% | 595 | 6.39M |
| 259 | NGEN | NervGen Pharma Corp. | 347.27M | 15.65% | 303,527 | - |
| 260 | DMAC | DiaMedica Therapeutics Inc. | 345.93M | -5.17% | 232,340 | - |
| 261 | IMRX | Immuneering Corporation | 344.60M | 1.14% | 532,176 | - |
| 262 | PBYI | Puma Biotechnology, Inc. | 343.93M | 5.79% | 367,996 | 228.37M |
| 263 | BCYC | Bicycle Therapeutics plc | 341.56M | 5.60% | 580,745 | 72.59M |
| 264 | NGNE | Neurogene Inc. | 337.34M | 7.44% | 79,664 | 925.00K |
| 265 | IRD | Opus Genetics, Inc. | 333.69M | 3.08% | 602,409 | 14.20M |
| 266 | CLYM | Climb Bio, Inc. | 331.99M | 1.46% | 768,909 | - |
| 267 | SRZN | Surrozen, Inc. | 326.68M | -2.37% | 30,856 | 3.48M |
| 268 | RZLT | Rezolute, Inc. | 325.12M | 2.62% | 1,840,415 | - |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 318.10M | -4.41% | 121,058 | - |
| 270 | PALI | Palisade Bio, Inc. | 311.86M | 7.43% | 5,277,497 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 308.46M | 7.74% | 1,164,960 | 1.00 |
| 272 | CABA | Cabaletta Bio, Inc. | 298.34M | -0.37% | 1,661,785 | - |
| 273 | LENZ | LENZ Therapeutics, Inc. | 293.16M | 2.19% | 1,386,499 | 19.09M |
| 274 | ANL | Adlai Nortye Ltd. | 291.51M | 14.16% | 551,115 | -1.35M |
| 275 | FHTX | Foghorn Therapeutics Inc. | 287.63M | 2.51% | 89,140 | 30.91M |
| 276 | AVXL | Anavex Life Sciences Corp. | 287.28M | 0.98% | 1,345,723 | - |
| 277 | OVID | Ovid Therapeutics Inc. | 284.85M | -2.70% | 1,404,507 | 7.25M |
| 278 | PRLD | Prelude Therapeutics Incorporated | 284.74M | 0.88% | 139,842 | 12.14M |
| 279 | NBP | NovaBridge Biosciences | 283.62M | - | 1,972,429 | - |
| 280 | ALEC | Alector, Inc. | 279.22M | 17.67% | 3,303,777 | 21.05M |
| 281 | ACIU | AC Immune SA | 276.77M | 1.45% | 198,671 | 4.51M |
| 282 | TARA | Protara Therapeutics, Inc. | 272.59M | -3.26% | 617,355 | - |
| 283 | SABS | SAB Biotherapeutics, Inc. | 271.97M | 1.04% | 1,320,380 | 114.70K |
| 284 | SLGL | Sol-Gel Technologies Ltd. | 270.71M | 4.53% | 56,989 | 19.39M |
| 285 | CCCC | C4 Therapeutics, Inc. | 263.46M | 2.66% | 2,423,415 | 35.95M |
| 286 | ABEO | Abeona Therapeutics Inc. | 261.28M | 2.23% | 847,599 | 5.82M |
| 287 | CHRS | Coherus Oncology, Inc. | 260.81M | 2.96% | 793,767 | 42.17M |
| 288 | ALXO | ALX Oncology Holdings Inc. | 260.58M | -1.25% | 379,511 | - |
| 289 | SLN | Silence Therapeutics plc | 258.37M | 3.80% | 252,507 | 559.00K |
| 290 | EDIT | Editas Medicine, Inc. | 255.45M | 5.67% | 2,063,110 | 40.52M |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 253.98M | 2.12% | 98,757 | 33.48M |
| 292 | CLLS | Cellectis S.A. | 253.71M | 6.62% | 62,131 | 79.59M |
| 293 | HELP | Cybin Inc. | 249.68M | 3.96% | 658,104 | - |
| 294 | CNTX | Context Therapeutics Inc. | 243.48M | 1.15% | 333,035 | - |
| 295 | NERV | Minerva Neurosciences, Inc. | 242.34M | -7.13% | 165,030 | - |
| 296 | VYGR | Voyager Therapeutics, Inc. | 237.80M | 3.37% | 507,915 | 40.37M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 231.56M | 1.13% | 31,899 | 3.50M |
| 298 | KROS | Keros Therapeutics, Inc. | 230.50M | 5.89% | 625,144 | 244.06M |
| 299 | ENLV | Enlivex Ltd. | 228.43M | 3.46% | 481,970 | - |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 227.90M | -2.60% | 1,038,703 | - |
| 301 | OABI | OmniAb, Inc. | 225.86M | -0.64% | 398,968 | 18.67M |
| 302 | ARCT | Arcturus Therapeutics Holdings Inc. | 223.12M | 1.68% | 820,656 | 82.03M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 220.99M | 4.23% | 153,745 | 44.64M |
| 304 | ADAG | Adagene Inc. | 217.28M | 17.60% | 222,927 | 103.20K |
| 305 | MDWD | MediWound Ltd. | 208.10M | 0.56% | 103,455 | 16.96M |
| 306 | CGEN | Compugen Ltd. | 208.02M | 3.29% | 217,165 | 72.76M |
| 307 | NVCT | Nuvectis Pharma, Inc. | 201.34M | -1.68% | 33,403 | - |
| 308 | ELTX | Elicio Therapeutics, Inc. | 196.10M | -0.28% | 48,358 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.33M | -0.51% | 452,685 | 13.11M |
| 310 | CRBU | Caribou Biosciences, Inc. | 192.31M | 4.74% | 1,256,151 | 11.16M |
| 311 | MGNX | MacroGenics, Inc. | 184.31M | 0.35% | 424,772 | 149.50M |
| 312 | ABOS | Acumen Pharmaceuticals, Inc. | 184.14M | 8.05% | 767,677 | - |
| 313 | KRRO | Korro Bio, Inc. | 182.45M | 11.75% | 278,653 | 6.39M |
| 314 | PRQR | ProQR Therapeutics N.V. | 180.17M | 5.56% | 679,665 | 19.19M |
| 315 | UNCY | Unicycive Therapeutics, Inc. | 179.69M | 8.21% | 1,166,465 | - |
| 316 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.01M | 6.28% | 201,505 | - |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 176.45M | 0.92% | 864,468 | 52.74M |
| 318 | GALT | Galectin Therapeutics Inc. | 176.42M | -3.94% | 739,420 | - |
| 319 | MENS | Jyong Biotech Ltd. | 175.33M | 6.05% | 247,098 | - |
| 320 | SGMT | Sagimet Biosciences Inc. | 170.75M | 0.19% | 313,051 | - |
| 321 | RNAC | Cartesian Therapeutics, Inc. | 169.39M | 3.90% | 103,929 | 2.80M |
| 322 | ACHV | Achieve Life Sciences, Inc. | 167.17M | 6.80% | 754,056 | - |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 167.08M | 2.61% | 239,435 | 7.15M |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 166.92M | -0.92% | 276,596 | - |
| 325 | ARTV | Artiva Biotherapeutics, Inc. | 166.84M | 4.81% | 224,147 | 251.00K |
| 326 | ZNTL | Zentalis Pharmaceuticals, Inc. | 166.41M | 9.83% | 373,520 | 26.87M |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 160.67M | 10.08% | 2,825,560 | 1.55M |
| 328 | TLSA | Tiziana Life Sciences Ltd | 159.53M | 6.84% | 122,163 | - |
| 329 | CDXS | Codexis, Inc. | 158.11M | 6.75% | 1,483,334 | 70.39M |
| 330 | NKTX | Nkarta, Inc. | 156.13M | 3.79% | 805,203 | - |
| 331 | CNTB | Connect Biopharma Holdings Limited | 152.06M | 3.82% | 888,139 | 64.00K |
| 332 | HRTX | Heron Therapeutics, Inc. | 151.49M | 0.42% | 1,114,075 | 154.90M |
| 333 | IMUX | Immunic, Inc. | 150.03M | 3.60% | 1,873,018 | - |
| 334 | TNYA | Tenaya Therapeutics, Inc. | 147.78M | -1.65% | 1,683,245 | - |
| 335 | CBUS | Cibus, Inc. | 147.01M | -2.53% | 647,462 | 3.64M |
| 336 | DTIL | Precision BioSciences, Inc. | 146.82M | 3.45% | 121,216 | 34.26M |
| 337 | FATE | Fate Therapeutics, Inc. | 144.17M | 3.33% | 707,307 | 6.65M |
| 338 | MOLN | Molecular Partners AG | 143.73M | 0.91% | 4,440 | 856.30K |
| 339 | SPRO | Spero Therapeutics, Inc. | 141.83M | 4.70% | 402,098 | 66.80M |
| 340 | KLRS | Kalaris Therapeutics, Inc. | 136.08M | 2.86% | 38,416 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 135.25M | -0.06% | 108,790 | 2.00M |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 133.48M | 9.39% | 1,100,589 | 70.00M |
| 343 | HUMA | Humacyte, Inc. | 131.41M | -2.44% | 6,130,839 | 2.04M |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 131.20M | 4.49% | 587,601 | 146.07M |
| 345 | AGEN | Agenus Inc. | 130.55M | 1.80% | 324,902 | 114.20M |
| 346 | ACOG | Alpha Cognition Inc. | 129.58M | 8.56% | 179,040 | 10.22M |
| 347 | EQ | Equillium, Inc. | 128.98M | 2.00% | 359,047 | 4.39M |
| 348 | ANTX | AN2 Therapeutics, Inc. | 124.00M | 0.88% | 389,834 | - |
| 349 | IPHA | Innate Pharma S.A. | 122.33M | 7.03% | 11,900 | 10.57M |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 121.90M | -13.12% | 21,288 | 39.99K |
| 351 | PEPG | PepGen Inc. | 120.26M | -1.69% | 4,865,346 | - |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 120.22M | - | 531,087 | 65.34K |
| 353 | PMN | ProMIS Neurosciences, Inc. | 116.58M | 2.36% | 12,835 | - |
| 354 | GNLX | Genelux Corporation | 113.59M | 5.79% | 136,500 | 8.00K |
| 355 | CRDF | Cardiff Oncology, Inc. | 110.07M | -0.62% | 775,216 | 593.00K |
| 356 | BMEA | Biomea Fusion, Inc. | 107.73M | -2.61% | 1,312,211 | - |
| 357 | HURA | TuHURA Biosciences, Inc. | 103.00M | -9.50% | 380,976 | - |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 101.11M | -0.59% | 4,705,227 | - |
| 359 | ONCY | Oncolytics Biotech Inc. | 100.08M | 9.58% | 854,521 | - |
| 360 | SGMO | Sangamo Therapeutics, Inc. | 96.68M | 5.35% | 8,026,814 | 39.55M |
| 361 | SEER | Seer, Inc. | 95.92M | 1.19% | 301,675 | 16.58M |
| 362 | COYA | Coya Therapeutics, Inc. | 95.71M | 3.55% | 111,859 | 7.95M |
| 363 | SPRB | Spruce Biosciences, Inc. | 95.40M | 6.40% | 51,428 | 697.00K |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 94.48M | 3.97% | 129,608 | 35.58M |
| 365 | LONA | LeonaBio, Inc. | 93.55M | -2.53% | 10,546 | - |
| 366 | PYXS | Pyxis Oncology, Inc. | 92.36M | 0.68% | 197,817 | 13.86M |
| 367 | TTRX | Turn Therapeutics Inc. | 91.72M | -2.66% | 41,253 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 91.20M | 5.43% | 134,884 | - |
| 369 | QTTB | Q32 Bio Inc. | 89.39M | -4.83% | 1,206,482 | 53.74M |
| 370 | AARD | Aardvark Therapeutics, Inc. | 89.23M | 8.49% | 420,629 | - |
| 371 | OKYO | OKYO Pharma Limited | 87.12M | 3.11% | 72,169 | - |
| 372 | GOSS | Gossamer Bio, Inc. | 85.66M | 11.11% | 10,666,071 | 48.47M |
| 373 | MCRB | Seres Therapeutics, Inc. | 84.93M | -0.11% | 36,506 | 789.00K |
| 374 | VANI | Vivani Medical, Inc. | 84.65M | - | 230,085 | - |
| 375 | PYPD | PolyPid Ltd. | 83.78M | 0.23% | 74,772 | - |
| 376 | ATYR | aTyr Pharma, Inc. | 83.42M | 9.08% | 1,801,784 | 190.00K |
| 377 | FLNA | Filana Therapeutics, Inc. | 83.09M | 1.78% | 265,135 | - |
| 378 | CSBR | Champions Oncology, Inc. | 82.14M | 2.87% | 7,118 | 57.95M |
| 379 | KZIA | Kazia Therapeutics Limited | 82.05M | -3.49% | 217,728 | 1.27M |
| 380 | GANX | Gain Therapeutics, Inc. | 81.95M | - | 574,705 | - |
| 381 | PLRX | Pliant Therapeutics, Inc. | 81.73M | 4.76% | 522,000 | - |
| 382 | MAIA | MAIA Biotechnology, Inc. | 81.30M | -4.29% | 384,480 | - |
| 383 | NRXS | NeurAxis, Inc. | 80.33M | -2.97% | 83,232 | 3.57M |
| 384 | RANI | Rani Therapeutics Holdings, Inc. | 80.32M | 9.61% | 2,329,445 | 1.63M |
| 385 | CGTX | Cognition Therapeutics, Inc. | 79.65M | 17.37% | 2,937,096 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 76.66M | -11.47% | 620,168 | 62.30M |
| 387 | GRCE | Grace Therapeutics, Inc. | 75.51M | 5.40% | 741,371 | - |
| 388 | ACET | Adicet Bio, Inc. | 73.95M | 1.03% | 77,959 | - |
| 389 | GUTS | Fractyl Health, Inc. | 73.72M | 1.51% | 2,067,583 | 3.00K |
| 390 | PMVP | PMV Pharmaceuticals, Inc. | 71.73M | 8.47% | 516,228 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 71.47M | 1.38% | 7,953 | 16.80M |
| 392 | NRXP | NRx Pharmaceuticals, Inc. | 71.36M | 1.41% | 417,597 | 1.23M |
| 393 | XBIT | XBiotech Inc. | 71.34M | -0.43% | 14,040 | - |
| 394 | DWTX | Dogwood Therapeutics, Inc. | 71.15M | 0.95% | 65,977 | - |
| 395 | EXOZ | eXoZymes, Inc. | 70.90M | 12.38% | 14,075 | -700.00 |
| 396 | BYSI | BeyondSpring Inc. | 70.31M | 4.27% | 12,311 | 1.88M |
| 397 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.20M | 0.53% | 23,526 | 1.36M |
| 398 | MNOV | MediciNova, Inc. | 69.89M | 4.01% | 56,726 | 409.66K |
| 399 | CING | Cingulate Inc. | 69.89M | -3.22% | 411,478 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 67.90M | 4.49% | 4,453 | 4.43M |
| 401 | LPCN | Lipocine Inc. | 67.52M | 15.77% | 171,177 | 1.98M |
| 402 | IBIO | iBio, Inc. | 67.36M | 2.63% | 501,115 | 300.00K |
| 403 | IBO | Impact BioMedical Inc. | 66.18M | 2.30% | 109,543 | 32.00K |
| 404 | IFRX | InflaRx N.V. | 65.28M | 0.96% | 386,135 | 34.44K |
| 405 | ANVS | Annovis Bio, Inc. | 60.11M | -4.93% | 480,939 | - |
| 406 | ACTU | Actuate Therapeutics, Inc. | 59.04M | -9.12% | 99,531 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 58.61M | 1.98% | 636,209 | 10.33M |
| 408 | ICCC | ImmuCell Corporation | 57.44M | 0.32% | 7,534 | 27.64M |
| 409 | HYFT | MindWalk Holdings Corp. | 56.62M | 0.88% | 98,195 | 20.70M |
| 410 | ACRV | Acrivon Therapeutics, Inc. | 56.57M | 5.04% | 543,105 | - |
| 411 | IMA | ImageneBio, Inc. | 56.48M | 1.00% | 35,282 | 800.00K |
| 412 | OKUR | OnKure Therapeutics, Inc. | 55.65M | -1.69% | 282,002 | - |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.55M | -0.27% | 110,268 | - |
| 414 | TIL | Instil Bio, Inc. | 53.98M | -3.40% | 22,543 | - |
| 415 | OSTX | OS Therapies Incorporated | 53.77M | -3.55% | 353,442 | - |
| 416 | ENTX | Entera Bio Ltd. | 53.15M | 2.70% | 67,782 | 42.00K |
| 417 | MREO | Mereo BioPharma Group plc | 52.67M | - | 1,871,510 | 500.00K |
| 418 | RADX | Radiopharm Theranostics Limited | 51.63M | 0.47% | 35,623 | 10.86M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 50.41M | - | 487,970 | 25.21M |
| 420 | INKT | MiNK Therapeutics, Inc. | 49.62M | 0.38% | 55,993 | - |
| 421 | XLO | Xilio Therapeutics, Inc. | 49.04M | 0.83% | 45,990 | 43.77M |
| 422 | ALGS | Aligos Therapeutics, Inc. | 47.89M | 5.05% | 62,783 | 2.19M |
| 423 | HOWL | Werewolf Therapeutics, Inc. | 46.58M | 15.11% | 813,604 | 1.14M |
| 424 | IMMP | Immutep Limited | 46.53M | 5.41% | 508,145 | 5.28M |
| 425 | EDSA | Edesa Biotech, Inc. | 46.33M | 6.12% | 523,256 | - |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | 1.54% | 87,107 | - |
| 427 | LSTA | Lisata Therapeutics, Inc. | 45.25M | - | 47,324 | 170.00K |
| 428 | NTRB | Nutriband Inc. | 44.86M | 4.53% | 3,429 | 2.28M |
| 429 | ESLA | Estrella Immunopharma, Inc. | 44.80M | -0.94% | 87,953 | - |
| 430 | RLYB | Rallybio Corporation | 44.43M | -6.35% | 31,745 | 858.00K |
| 431 | SNSE | Sensei Biotherapeutics, Inc. | 44.02M | 10.37% | 67,816 | - |
| 432 | ATOS | Atossa Therapeutics, Inc. | 44.00M | -2.85% | 63,315 | - |
| 433 | RNXT | RenovoRx, Inc. | 43.74M | -3.96% | 462,384 | 1.12M |
| 434 | NBY | NovaBay Pharmaceuticals, Inc. | 42.33M | 6.71% | 213,155 | 10.30M |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 42.28M | 9.30% | 79,759 | 120.77M |
| 436 | LITS | Lite Strategy, Inc. | 41.09M | -2.59% | 222,920 | - |
| 437 | CELU | Celularity Inc. | 37.78M | -1.50% | 5,417 | 40.58M |
| 438 | NXTC | NextCure, Inc. | 37.49M | -1.40% | 8,934 | - |
| 439 | CRVO | CervoMed Inc. | 37.03M | 1.52% | 24,723 | 4.01M |
| 440 | VERU | Veru Inc. | 36.92M | 4.07% | 24,932 | 16.89M |
| 441 | RNTX | Rein Therapeutics Inc. | 33.93M | -6.92% | 32,876 | - |
| 442 | PLUR | Pluri Inc. | 33.67M | -1.33% | 2,820 | 1.34M |
| 443 | PTN | Palatin Technologies, Inc. | 33.64M | -1.26% | 13,578 | 8.96M |
| 444 | PDSB | PDS Biotechnology Corporation | 33.18M | 0.21% | 128,558 | - |
| 445 | EVAX | Evaxion A/S | 32.86M | 5.91% | 21,170 | 7.53M |
| 446 | LGVN | Longeveron Inc. | 32.79M | 7.69% | 1,518,591 | 1.20M |
| 447 | INMB | INmune Bio Inc. | 32.70M | 8.85% | 493,767 | 50.00K |
| 448 | APLM | Apollomics, Inc. | 31.61M | -7.13% | 4,678 | 6.93M |
| 449 | DYAI | Dyadic International, Inc. | 31.05M | 3.91% | 39,938 | 3.09M |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 30.86M | -0.53% | 128,973 | 90.00K |
| 451 | BCTX | BriaCell Therapeutics Corp. | 29.91M | -1.19% | 87,076 | - |
| 452 | HYPD | Hyperion DeFi, Inc. | 29.36M | -5.22% | 323,666 | 813.46K |
| 453 | KYNB | Kyntra Bio, Inc. | 28.73M | 4.72% | 30,834 | 6.44M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 28.14M | -5.66% | 177,515 | - |
| 455 | CVM | CEL-SCI Corporation | 27.76M | 6.85% | 52,652 | - |
| 456 | DARE | Daré Bioscience, Inc. | 27.66M | 4.40% | 140,047 | 1.03M |
| 457 | QNTM | Quantum BioPharma Ltd. | 27.24M | -8.70% | 1,158,070 | - |
| 458 | PSTV | Plus Therapeutics, Inc. | 26.73M | -4.18% | 20,935,726 | 5.21M |
| 459 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.70M | -0.16% | 75,899 | - |
| 460 | ABVC | ABVC BioPharma, Inc. | 26.69M | 11.33% | 141,319 | 797.92K |
| 461 | XCUR | Exicure, Inc. | 26.64M | -1.76% | 25,047 | 500.00K |
| 462 | SNTI | Senti Biosciences, Inc. | 26.13M | 3.31% | 146,773 | 22.00K |
| 463 | SER | Serina Therapeutics, Inc. | 26.11M | 9.28% | 593,983 | 130.00K |
| 464 | IGC | IGC Pharma, Inc. | 26.01M | 3.19% | 236,480 | 1.11M |
| 465 | BOLD | Boundless Bio, Inc. | 25.43M | 3.18% | 65,588 | - |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 25.38M | 0.66% | 63,808 | - |
| 467 | PASG | Passage Bio, Inc. | 25.18M | - | 17,306 | - |
| 468 | AEON | AEON Biopharma, Inc. | 24.76M | -0.67% | 104,124 | - |
| 469 | CYCN | Cyclerion Therapeutics, Inc. | 24.28M | 311.61% | 264,644,078 | 2.07M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 23.80M | 5.09% | 816,936 | 789.00K |
| 471 | TPST | Tempest Therapeutics, Inc. | 23.24M | -1.22% | 102,706 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 22.39M | -8.70% | 671,223 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 22.21M | 1.23% | 69,042 | 14.99M |
| 474 | SKYE | Skye Bioscience, Inc. | 22.19M | 8.18% | 561,765 | - |
| 475 | BRNS | Barinthus Biotherapeutics plc | 22.06M | -5.08% | 7,495 | 14.97M |
| 476 | OTLK | Outlook Therapeutics, Inc. | 21.97M | 2.04% | 1,498,188 | 205.70K |
| 477 | MRKR | Marker Therapeutics, Inc. | 21.84M | 0.77% | 72,979 | 3.55M |
| 478 | LEXX | Lexaria Bioscience Corp. | 21.56M | 11.04% | 253,525 | 522.00K |
| 479 | CRIS | Curis, Inc. | 21.31M | -2.61% | 352,932 | 9.44M |
| 480 | NNVC | NanoViricides, Inc. | 20.61M | 4.66% | 147,742 | - |
| 481 | PLRZ | Polyrizon Ltd. | 20.46M | 7.96% | 43,751 | - |
| 482 | VYNE | VYNE Therapeutics Inc. | 20.19M | 1.42% | 120,873 | 570.00K |
| 483 | CUE | Cue Biopharma, Inc. | 19.79M | -11.87% | 1,387,978 | 27.47M |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.87M | -6.32% | 409,345 | 3.94M |
| 485 | TVGN | Tevogen Bio Holdings Inc. | 18.66M | -0.88% | 23,494 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 18.17M | 3.67% | 133,012 | 320.00K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.18M | 0.30% | 7,913,527 | - |
| 488 | GNTA | Genenta Science S.p.A. | 16.33M | 3.75% | 19,921 | - |
| 489 | LTRN | Lantern Pharma Inc. | 15.92M | 3.65% | 1,261,642 | - |
| 490 | PHIO | Phio Pharmaceuticals Corp. | 15.10M | 6.56% | 475,535 | - |
| 491 | OSRH | OSR Holdings, Inc. | 15.06M | -2.72% | 1,159,706 | -90.52K |
| 492 | INTS | Intensity Therapeutics, Inc. | 14.45M | -3.24% | 15,427 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 14.22M | -4.30% | 121,328 | 1.23M |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.06M | 0.99% | 28,149 | - |
| 495 | INAB | IN8bio, Inc. | 13.79M | -5.41% | 60,526 | - |
| 496 | TRAW | Traws Pharma, Inc. | 13.26M | -9.29% | 132,917 | 2.85M |
| 497 | JUNS | Jupiter Neurosciences, Inc. | 13.07M | 0.93% | 120,123 | - |
| 498 | GTBP | GT Biopharma, Inc. | 12.92M | 0.32% | 596,293 | - |
| 499 | BCDA | BioCardia, Inc. | 12.69M | -4.13% | 62,635 | 3.00K |
| 500 | KAPA | Kairos Pharma, Ltd. | 12.05M | 3.54% | 100,055 | - |